Pseudomonas aeruginosa is responsible for a substantial fraction of hospital infections. Twenty-five European university hospitals submitted a total of 1411 Pseudomonas aeruginosa isolates for susceptibility testing during 1997 and 1998. The isolates showed highest susceptibility to amikacin (87.5%), meropenem (87.3%) and piperacillin/tazobactam (86.8%). Susceptibility to ciprofloxacin was 73.2%. There was no clear geographical distribution of resistance, although isolates from northwestern Europe tended to be more susceptible than those from southeastern Europe. Isolates that were resistant to one class of antibiotics were also often resistant to at least one other class of antibiotics. Imipenem-resistant isolates were generally not clonally related.

Antimicrobial resistance in European isolates of Pseudomonas aeruginosa / Fluit, A. C.; Verhoef, J.; Schmitz, F. J.; Mittermayer, H.; Struelens, M.; Goldstein, F.; Jarlier, V.; Etienne, J.; Courcol, P. R.; Daschner, F.; Hadding, U.; Legakis, N.; Schito, G. C.; Raponi, Giammarco; Heczko, P.; Hyrniewicz, W.; Costa, D.; Perea, E.; Baquero, F.; Martin, Alvarez; R., Bille; J., French; G., Andoni; R., Korten; V., Unal; S., Gür; D., Keller. - In: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. - ISSN 0934-9723. - STAMPA. - 19 (5):(2000), pp. 370-374.

Antimicrobial resistance in European isolates of Pseudomonas aeruginosa

RAPONI, Giammarco;
2000

Abstract

Pseudomonas aeruginosa is responsible for a substantial fraction of hospital infections. Twenty-five European university hospitals submitted a total of 1411 Pseudomonas aeruginosa isolates for susceptibility testing during 1997 and 1998. The isolates showed highest susceptibility to amikacin (87.5%), meropenem (87.3%) and piperacillin/tazobactam (86.8%). Susceptibility to ciprofloxacin was 73.2%. There was no clear geographical distribution of resistance, although isolates from northwestern Europe tended to be more susceptible than those from southeastern Europe. Isolates that were resistant to one class of antibiotics were also often resistant to at least one other class of antibiotics. Imipenem-resistant isolates were generally not clonally related.
2000
Anti-Bacterial Agents, Drug Resistance; Microbial, Drug Resistance; Multiple, Europe, Hospitals; University, Humans, Microbial Sensitivity Tests, Pseudomonas aeruginosa, Pseudomonas Infections
01 Pubblicazione su rivista::01a Articolo in rivista
Antimicrobial resistance in European isolates of Pseudomonas aeruginosa / Fluit, A. C.; Verhoef, J.; Schmitz, F. J.; Mittermayer, H.; Struelens, M.; Goldstein, F.; Jarlier, V.; Etienne, J.; Courcol, P. R.; Daschner, F.; Hadding, U.; Legakis, N.; Schito, G. C.; Raponi, Giammarco; Heczko, P.; Hyrniewicz, W.; Costa, D.; Perea, E.; Baquero, F.; Martin, Alvarez; R., Bille; J., French; G., Andoni; R., Korten; V., Unal; S., Gür; D., Keller. - In: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. - ISSN 0934-9723. - STAMPA. - 19 (5):(2000), pp. 370-374.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/503503
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 35
social impact